Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Disease	Cell Type	Therapeutic or Technology	Institution	Stage	Project Objective	Details
Brain Injury, hypoxic, ischemic, Neurological Disorders, Pediatrics	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Sanford-Burnham		Pre-IND/IDE or Equivalent
Blood Cancer, Cancer, Multiple Myeloma	Adult or Tissue Stem Cell	Personalized cell therapy, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Neurological Disorders, Spinal Cord Injury	Embryonic Stem Cell	Donor cell therapy, Other Components, Therapeutic Approach	UCSD		Pre-IND/IDE or Equivalent
Neurological Disorders, Traumatic Brain Injury	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	UC Irvine		Pre-IND/IDE or Equivalent
Cancer, Ovarian Cancer, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	COH		Pre-IND/IDE or Equivalent
Blood Disorders, Hyper IgM Syndrome, Immune Disease	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Age-related macular degeneration, Vision Loss	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Stanford		Pre-IND/IDE or Equivalent
Bladder or Urinary Tract Disorder, Incontinence, Skeletal/Smooth Muscle disorders	iPS Cell	Personalized cell therapy, Therapeutic Approach	Stanford		Pre-IND/IDE or Equivalent
Epidermolysis Bullosa, Skin Disease	iPS Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Stanford		Pre-IND/IDE or Equivalent
Intestinal Disease, Metabolic Disorders, Neurological Disorders, Pediatrics	iPS Cell	Donor cell therapy, Therapeutic Approach	CHLA		Pre-IND/IDE or Equivalent
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML)		Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	COH		Clinical Trial, Phase 1 or Phase 1/2
Age-related macular degeneration, Vision Loss	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	Regenerative Patch Technologies LLC		Clinical Trial, Phase 2
Corneal Damage, Vision Loss	Adult or Tissue Stem Cell	Biologic, Exosomes based therapy, Therapeutic Approach	Combangio		Clinical Trial, Phase 2
HIV/AIDS, Infectious Disease	Other		COH		Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease, Hearing Loss, Intellectual Disability, Metabolic Disorders, Neurological Disorders, Vision Loss	Somatic Cell	Personalized cell therapy, Therapeutic Approach	Immusoft Corporation		Clinical Trial, Phase 1 or Phase 1/2
Anemia, Blood Disorders	Adult or Tissue Stem Cell	Antibody, Biologic, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Cancer, Solid Tumors		Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Eureka Therapeutics, Inc.		Clinical Trial, Phase 1 or Phase 1/2
B cell cancers, Blood Cancer, Cancer	Somatic Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	Angiocrine		Clinical Trial, Phase 3
Cancer, Colon Cancer, Solid Tumors			Tachyon Therapeutics, Inc		Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease, Osteoarthritis	Somatic Cell	Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	Genascence Corporation		Clinical Trial, Phase 1 or Phase 1/2
Anemia, Blood Disorders	Somatic Cell	Cell processing & handling, Immune tolerance/management, Technology	COH		Clinical Trial, Phase 1 or Phase 1/2
Anemia, Blood Disorders, Bone Marrow Transplant and Viral Infection	Adult or Tissue Stem Cell	Immune tolerance/management, Technology	Stanford		Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS, Infectious Disease		Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	Excision BioTherapeutics		Clinical Trial, Phase 1 or Phase 1/2
Epilepsy, Neurological Disorders	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	Neurona Therapeutics		Clinical Trial, Phase 1 or Phase 1/2
Bladder or Urinary Tract Disorder, Skeletal/Smooth Muscle disorders	Somatic Cell	Technology, Tissue engineering	Wake Forest University Health Sciences		Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Cancer, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	COH		Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, IPEX Syndrome	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Muscle Injury, Skeletal/Smooth Muscle disorders	Adult or Tissue Stem Cell	Personalized cell therapy, Therapeutic Approach	UC Davis		Clinical Trial, Phase 1 or Phase 1/2
Heart Disease, Heart failure	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Cancer, Solid Tumors	Adult or Tissue Stem Cell	Personalized cell therapy, Therapeutic Approach	BioEclipse Therapeutics INC.		Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Cancer, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
B cell cancers, Blood Cancer, Cancer, Leukemia, Leukemia, Acute Myeloid (AML)	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Stroke	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Cancer, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	COH		Clinical Trial, Phase 1 or Phase 1/2
Amyotrophic Lateral Sclerosis, Neurological Disorders	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	Cedars-Sinai		Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML)	Cancer Stem Cell	Antibody, Biologic, Therapeutic Approach	Immune-Onc Therapeutics		Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Spina Bifida	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	UC Davis		Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS, Immune Disease, Infectious Disease	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCSF		Clinical Trial, Phase 1 or Phase 1/2
Corneal Damage, Vision Loss	Adult or Tissue Stem Cell	Personalized cell therapy, Therapeutic Approach	UCLA		Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Parkinson's Disease	Vital Research Opportunity	Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	Brain Neurotherapy Bio		Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa, Vision Loss	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Cedars-Sinai		Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Breast Cancer, Cancer, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	COH		Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Immune Disease, Leukocyte Adhesion Deficiency	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Rocket Pharmaceuticals, Inc.		Clinical Trial, Phase 1 or Phase 1/2
Cystinosis, Kidney Disease, Kidney Failure, Metabolic Disorders	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCSD		Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa, Vision Loss		Therapeutic Approach	jCyte		Clinical Trial, Phase 2
Diabetes, Metabolic Disorders, Type 1 diabetes	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	UCSF		Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Severe Combined Immunodeficiency, X-linked (X-SCID)	Adult or Tissue Stem Cell	Antibody, Biologic, Therapeutic Approach	Jasper Therapeutics, Inc.		Clinical Trial, Phase 1 or Phase 1/2
Cancer, Sarcoma, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCLA		Clinical Trial, Phase 1 or Phase 1/2
Kidney Disease, Kidney Failure	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
B cell cancers, Blood Cancer, Cancer, Leukemia	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2